Clinical Trials Insight: 700030638
Phase of Trial: Phase III
Latest Information Update: 31 Oct 2008
At a glance
- Drugs AVE 2268 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Sponsors Sanofi
- 31 Oct 2008 Sanaofi-aventis has decided to discontiune development of AVE-2268 according to media release.
- 18 Feb 2008 New trial record.